Related Experiment Video

Updated: Aug 5, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

MYC in Oncogenesis and Therapeutic Implications

Na Zhang1, Li Wei2, Cuiping Tang1

  • 1Department of Pediatric Oncology Sichuan Clinical Research Center for Cancer Sichuan Cancer Hospital & Institute Sichuan Cancer Center Affiliated Cancer Hospital of University of Electronic Science and Technology of China Chengdu China.

Medcomm
|July 28, 2026
PubMed

Insights

The MYC oncogene family plays a complex role in cancer development. Understanding its interactions and targeting MYC offers new therapeutic strategies for various cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The MYC oncogene family is a key regulator in tumorigenesis, exhibiting complex interactions.
  • Recent research highlights the dynamic interplay among MYC family members, influencing lineage-specific oncogenic programs.

Purpose of the Study:

  • To synthesize emerging insights into MYC's role in tumor microenvironment remodeling, noncoding RNA regulation, and metabolic reprogramming.
  • To critically evaluate current and emerging therapeutic strategies targeting MYC and its downstream networks.
  • To discuss MYC's prognostic significance and challenges in translating preclinical findings to clinical outcomes.

Main Methods:

  • Literature review synthesizing recent advances in MYC oncogene research.
  • Analysis of MYC's mechanisms in driving therapeutic resistance and tumor progression.
  • Evaluation of diverse therapeutic strategies including direct inhibitors, pathway inhibitors, synthetic lethality, and combination therapies.

Main Results:

  • MYC orchestrates tumor microenvironment remodeling and metabolic reprogramming.
  • MYC contributes to therapeutic resistance across various cancer types.
  • A significant gap exists between preclinical efficacy and clinical outcomes for MYC-targeted therapies.

Conclusions:

  • MYC is a multidimensional regulatory node with context-dependent functions.
  • Targeting MYC and its networks presents challenges but offers promising therapeutic opportunities.
  • Emerging combination strategies are crucial for overcoming acquired drug resistance and improving clinical outcomes.
Keywords:
clinical trialsindirect targetingmechanismmyc oncogenetherapeutic targets

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...